RxDoctor Payments DataLook up a doctor →

Meaghan Schenk

Family · Jackson, MSNPI 1922515493

Payments from drug & device makers

$11,798in general payments, 2019–2025

Across 571 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$849
  • Merck$795
  • Bristol Myers Squibb$737
  • Incyte Corporation$548
  • AstraZeneca$526
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis63$1,465
Johnson & Johnson51$849
Merck44$795
Bristol Myers Squibb29$737
Incyte Corporation25$548
AstraZeneca(2 entities)26$526
Pfizer30$494
Amgen18$426
Genentech USA, Inc.18$331
Daiichi Sankyo Inc.12$295
Pharmacosmos Therapeutics Inc.14$266
Seagen Inc.10$258
AVEO Pharmaceuticals, Inc.8$252
Astellas Pharma US Inc13$241
Takeda Pharmaceuticals U.S.A., Inc.12$231
Beigene USA, Inc.12$227
Sanofi12$225
Gilead(2 entities)8$223
GSK11$223
Puma Biotechnology, Inc.7$209
E.r. Squibb & Sons, L.L.C.8$205
Lilly USA, LLC10$188
Karyopharm Therapeutics Inc.11$184
Eisai Inc.9$177
AbbVie7$171
Bayer6$134
Tersera Therapeutics LLC5$129
Deciphera Pharmaceuticals Inc.6$128
Array Biopharma Inc7$120
Stemline Therapeutics Inc.3$98
Genmab U.S., Inc.5$97
Taiho Oncology, Inc.5$87
Regeneron Healthcare Solutions, Inc.4$85
Exelixis Inc.5$76
EMD Serono, Inc.4$73
Sobi, Inc3$73
Boehringer Ingelheim4$66
Ipsen Biopharmaceuticals, Inc2$58
Pharmacyclics LLC, An Abbvie Company4$57
Rigel Pharmaceuticals, Inc.3$56
Blueprint Medicines Corporation2$54
Jazz Pharmaceuticals Inc.2$44
Apellis Pharmaceuticals, Inc.3$44
Alnylam Pharmaceuticals Inc.2$42
G1 Therapeutics, Inc.2$42
Shield Therapeutics Inc2$41
Pharmaessentia USA Corporation2$41
Caris MPI, Inc.2$39
Coherus Oncology, Inc.1$29
Morphosys, US Inc.2$29
Fennec Pharmaceuticals, Inc.1$25
Sandoz1$24
Spectrum Pharmaceuticals Inc.1$24
Octapharma USA, Inc.1$23
Novocure Inc.1$22
Beone Medicines USA, Inc.1$22
Legend Biotech USA Inc.1$20
Tempus AI, Inc1$18
Iovance Biotherapeutics, Inc.1$17
Servier Pharmaceuticals LLC1$17

How this compares

$11,798 in reported general payments places this provider in the 95th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$1,867,044
Medicare patients
297
Services billed
78,320

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →